Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Dexatab is used in the following conditions. Allergic states: to control severe or disabling allergic conditions that have not responded to adequate trials of conventional treatment, including asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. Collagen diseases: such as lupus erythematosus and rheumatoid arthritis. Dermatologic diseases: bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. Gastrointestinal diseases: regional enteritis and ulcerative colitis. Hematologic disorders: acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults, and selected cases of secondary thrombocytopenia. Neoplastic diseases: leukemias and lymphomas. Nervous system disorders: acute exacerbations of multiple sclerosis, and cerebral edema associated with a primary or metastatic brain tumor, craniotomy, or head injury. Ophthalmic diseases: temporal arteritis, uveitis, and ocular inflammatory conditions that do not respond to topical corticosteroids. Renal diseases: to induce diuresis or bring about remission of proteinuria in idiopathic nephrotic syndrome or nephrotic syndrome due to lupus erythematosus. Respiratory diseases: berylliosis, fulminating or disseminated pulmonary tuberculosis when used together with appropriate antituberculous treatment, idiopathic eosinophilic pneumonias, and symptomatic sarcoidosis. Rheumatic disorders: as adjunctive therapy for short-term use to help the patient through an acute episode or flare of acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis, including juvenile rheumatoid arthritis (some cases may need low-dose maintenance therapy); also for dermatomyositis, polymyositis, and systemic lupus erythematosus. Miscellaneous uses: diagnostic testing of adrenocortical hyperfunction, trichinosis with neurologic or myocardial involvement, and tuberculous meningitis with subarachnoid block or impending block when used together with appropriate antituberculous treatment.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Dexamethasone is a synthetic glucocorticoid that reduces inflammation by stopping white blood cells from migrating to affected tissue and reversing increased capillary permeability. It also suppresses the normal immune response.

Pregnancy & Breastfeeding

Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Glucocorticoids appear in breast milk. Mothers taking high dosages of corticosteroids should be advised not to breast-feed.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: In general, glucocorticoid dosage depends on the severity of the condition and the response of the patient. If no favourable response is noted within a couple of days, continuing glucocorticoid therapy is not advisable. In chronic conditions requiring long term therapy, the lowest dosage that gives adequate, though not necessarily complete, relief should be used. For tablets, in adult patients daily oral dosages vary from 1 mg to 10 mg, and in children from 0.03 to 0.20 mg per kg body weight, according to the individual response. In some patients higher dosages may be needed temporarily to control the disease. As soon as circumstances permit, the dosage should be decreased. For a short dexamethasone suppression test, 1 mg of dexamethasone is given at 11 p.m. and plasma cortisol is measured the next morning. Patients who do not show a decrease in cortisol can be given a longer test, in which 0.5 mg of dexamethasone is given at 6 hour intervals for 48 hours, followed by 2 mg every 6 hours for a further 48 hours. Twenty four hour urine collections are made before, during and at the end of the test to determine 17 alpha hydroxycorticoids. For injection, dexamethasone can be given by intravenous, intramuscular or local injection. Dexamethasone injections can also be diluted with an infusion fluid or injected directly into the infusion line. Intravenous injections of large doses should be given slowly, over several minutes. Intramuscular administration should be given by deep intramuscular injection to prevent atrophy of the subcutaneous fatty tissue. Intra articular injections should be given under strictly aseptic conditions, since glucocorticoids reduce resistance to infection. When diluted with these infusion fluids, dexamethasone keeps its potency for at least 24 hours at room temperature and in daylight conditions. Sodium chloride 0.9%, anhydrous glucose 5%, invert sugar 10%, sorbitol 5%, Ringer's solution and Hartman's solution, also known as Ringer lactate, can be used as infusion fluids among others. The dosage of dexamethasone depends on the severity of the condition and the response of the patient. For systemic therapy in adults, daily doses of 0.05 to 0.20 mg per kg body weight are usually sufficient. For emergencies, such as anaphylaxis, acute severe asthma or cerebral edema, substantially higher doses are required. An initial dose of 10 to 20 mg IV is followed by 6 mg IV or IM every 6 hours, until a satisfactory result is obtained, after which the dosage has to be tapered off gradually. For local therapy, the following doses are recommended. Intra articularly, 2 to 4 mg in large joints and 0.8 to 1 mg in small joints. Intrabursally, 2 to 4 mg, and in tendon sheaths, 0.4 to 1 mg. The frequency of these injections may vary from every 3 to 5 days to every 2 to 3 weeks.

Side Effects & Interactions